ArticleScientific reports2025
Transparent brain tumor detection using DenseNet169 and LIME.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ResSGA-Net: A deep learning approach for enhanced brain tumor detection and accurate classification in healthcare imaging systems.Journal, genetic engineering & biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A crucial area of research in the field of medical imaging is that of brain tumor classification, which greatly aids diagnosis and facilitates treatment planning. This paper proposes DenseNet169-LIME-TumorNet, a model based on deep learning and an integrated combination of DenseNet169 with LIME to boost the performance of brain tumor classification and its interpretability. The model was trained and evaluated on the publicly available Brain Tumor MRI Dataset containing 2,870 images spanning three tumor types. Dense169-LIME-TumorNet achieves a classification accuracy of 98.78%, outperforming widely used architectures including Inception V3, ResNet50, MobileNet V2, EfficientNet variants, and other DenseNet configurations. The integration of LIME provides visual explanations that enhance transparency and reliability in clinical decision-making. Furthermore, the model demonstrates minimal computational overhead, enabling faster inference and deployment in resource-constrained clinical environments, thereby highlighting its practical utility for real-time diagnostic support. Work in the future should run towards creating generalization through the adoption of a multi-modal learning approach, hybrid deep learning development, and real-time application development for AI-assisted diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.